A detailed history of American Century Companies Inc transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 32,084 shares of ZNTL stock, worth $77,964. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,084
Previous 29,475 8.85%
Holding current value
$77,964
Previous $108,000 10.19%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$2.7 - $4.03 $7,044 - $10,514
2,609 Added 8.85%
32,084 $97,000
Q3 2024

Nov 12, 2024

BUY
$2.9 - $4.57 $17,872 - $28,164
6,163 Added 26.44%
29,475 $108,000
Q2 2024

Aug 07, 2024

BUY
$4.09 - $16.13 $95,346 - $376,022
23,312 New
23,312 $95,000

Others Institutions Holding ZNTL

About Zentalis Pharmaceuticals, Inc.


  • Ticker ZNTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,983,600
  • Market Cap $138M
  • Description
  • Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...
More about ZNTL
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.